Announced

Elliott to acquire a 21.67% stake in Integrated Diagnostics Holdings from Actis for $87m.

Synopsis

Elliott, an American investment management firm, agreed to acquire a 21.67% stake in Integrated Diagnostics Holdings, a London-listed healthcare company, from Actis, a private equity firm, for $87m.

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Elliott to acquire a 21.67% stake in Integrated Diagnostics Holdings from Actis for $87m.